Latest On Mirum Pharmaceuticals, Inc (MIRM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-07 08:03 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-05 03:10 EST | News | Mirum Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.17, revenue of $31.6M beats by $0.81M | N/A | |
| 2023-05-04 01:50 EST | News | Mirum Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-04-30 09:44 EST | News | Mirum Pharmaceuticals: Staying The Course | N/A | |
| 2023-04-13 08:06 EST | News | Mirum Pharmaceuticals prices notes worth $275M | N/A | |
| 2023-04-12 19:36 EST | News | Mirum Pharmaceuticals reports preliminary unaudited financial results for Q1 2023 | N/A | |
| 2023-03-09 03:57 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-14 11:04 EST | News | Mirum files for expanded approval of Livmarli in US | N/A | |
| 2023-02-01 18:54 EST | News | Mirum Pharmaceuticals: In The Spotlight Following Buyout Of Albireo Pharma | N/A | |
| 2022-11-29 09:10 EST | News | Mirum drops plans to develop liver disease candidate in pregnancy | N/A | |
| 2022-11-20 19:55 EST | News | Mirum: Potential For European Approval To Move It Forward | N/A | |
| 2022-11-10 02:53 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-09 08:41 EST | News | Mirum Pharmaceuticals GAAP EPS of -$1.02 beats by $0.05, revenue of $18.78M misses by $2.03M | N/A | |
| 2022-10-25 00:08 EST | News | Mirum says liver disease therapy met main goal in late-stage study | N/A | |
| 2022-10-14 19:50 EST | News | Mirum's liver disease drug Livmarli gets EMA committee nod for approval in EU | N/A | |
| 2022-08-17 21:12 EST | News | Mirum: Great Sales Start For Livmarli Paves The Way For Long-Term Growth | N/A | |
| 2022-08-10 20:11 EST | News | Mirum Pharmaceuticals stock falls prices $80.0M stock offering | N/A | |
| 2022-08-10 02:57 EST | News | Mirum Pharmaceuticals falls aftermarket on $80M stock offering | N/A | |
| 2022-08-08 04:34 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-05 05:13 EST | News | Mirum Pharmaceuticals GAAP EPS of -$0.84 beats by $0.31, revenue of $17.5M beats by $2.08M | N/A | |
| 2022-08-03 23:16 EST | News | Mirum Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-05-27 23:11 EST | News | Mirum Pharmaceuticals: Post-Approval Execution Looks Excellent | N/A | |
| 2022-05-24 00:37 EST | News | Mirum acquires San Diego-based Satiogen in stock and cash combination | N/A | |
| 2022-05-08 01:25 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-07 04:44 EST | News | Mirum Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-06 05:07 EST | News | Mirum Pharmaceuticals GAAP EPS of -$1.17 beats by $0.23, revenue of $12.89M beats by $4.43M | N/A | |
| 2022-03-10 02:23 EST | News | Mirum Pharmaceuticals reports Q4 results | N/A | |
| 2022-03-10 02:23 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-09 09:31 EST | News | Mirum Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-02-12 01:19 EST | News | Mirum Pharmaceuticals grants stock options under inducement plan | N/A | |
| 2021-12-17 06:35 EST | News | Mirum Pharmaceuticals Gets The 'Thumbs Up' | N/A | |
| 2021-12-15 14:30 EST | News | Mirum Pharmaceuticals to join NASDAQ Biotechnology Index | N/A | |
| 2021-11-17 21:27 EST | News | Mirum Pharmaceuticals to sell Rare Pediatric Disease PRV for $110M | N/A | |
| 2021-11-16 04:18 EST | News | Mirum Pharmaceuticals reports Q3 results | N/A | |
| 2021-11-16 04:18 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-16 04:18 EST | News | Mirum Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-12 04:54 EST | News | Mirum Pharmaceuticals: Livmarli Approval Could Spark A Bull Run For This Young Biotech | N/A | |
| 2021-10-27 22:00 EST | News | Warning: MIRM is at high risk of performing badly | N/A | |
| 2021-09-29 19:13 EST | News | FDA approves Mirum Pharmaceuticals' Alagille syndrome treatment Livmarli | N/A | |
| 2021-09-22 00:37 EST | News | Mirum Pharmaceuticals (MIRM) Investor Presentation - Slideshow | N/A | |
| 2021-09-22 00:24 EST | News | Mirum submits application to EMA for maralixibat in Alagille Syndrome | N/A | |
| 2021-09-22 00:12 EST | News | Mirum and Takeda ink exclusive licensing agreement to commercialize maralixibat in Japan | N/A | |
| 2021-08-25 00:56 EST | News | Mirum And Maralixibat In Pediatric Cholestasis: The Differentiation | N/A | |
| 2021-08-08 15:26 EST | News | Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-06 06:42 EST | News | Mirum Pharmaceuticals beats on revenue | N/A | |
| 2021-07-27 13:01 EST | News | Mirum Pharma inks maralixibat development deal for rare liver disease in South Korea | N/A | |
| 2021-07-21 15:36 EST | News | Mirum Is Undervalued Despite Expected Tough Competition | N/A | |
| 2021-07-21 15:35 EST | News | Mirum Pharmaceuticals highlights maralixibat liver disease data analyses | N/A | |
| 2021-07-21 15:34 EST | News | Mirum adds veteran biotechnology executive Carol Brosgart to board of directors | N/A | |
| 2021-07-21 15:27 EST | News | Analysis shows safety of Mirum's maralixibat for liver disorder maintained over five years | N/A | |
About Mirum Pharmaceuticals, Inc (MIRM):
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California.
General
- Name Mirum Pharmaceuticals, Inc
- Symbol MIRM
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 68
- Fiscal Year EndDecember
- IPO Date2019-07-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.mirumpharma.com
View More
Valuation
- Price/Book (Most Recent Quarter) 4.53
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.56
- Next Year EPS Estimate -$2.39
- Next Quarter EPS Estimate -$0.64
- Return on Assets -34%
- Return on Equity -68%
- Earnings Per Share -$28.94
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 610.52 million
- PE Ratio -18.84
- Analyst Target Price $50.29
- Book Value Per Share $6.48
View More
Share Statistics
- Shares Outstanding 30.42 million
- Shares Float 12.19 million
- % Held by Insiders 909%
- % Held by Institutions 70.89%
- Shares Short 674051
- Shares Short Prior Month 637658
- Short Ratio 5.61
- Short % of Float 4%
- Short % of Shares Outstanding 2%
View More
Technicals
- 52 Week High $27.43
- 52 Week Low $10.14
- 50 Day Moving Average 19.23
- 200 Day Moving Average 19.6
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Mirum Pharmaceuticals, Inc (MIRM) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Mirum Pharmaceuticals, Inc (MIRM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-09 | $N/A | -$1.43 | -$0.98 | -45.49% |
| 2020-09-30 | 2020-11-12 | $N/A | -$0.86 | -$0.98 | 12.46% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.93 | -$0.87 | -6.5% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.86 | -$0.84 | -2.83% |
| 2019-12-31 | 2020-03-12 | $N/A | -$0.79 | -$0.85 | 6.73% |
| 2019-09-30 | 2019-11-06 | $N/A | -$0.84 | -$0.63 | -34.14% |
| 2019-06-30 | 2019-08-28 | $N/A | -$0.59 | -$0.59 | 0.47% |
Mirum Pharmaceuticals, Inc (MIRM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Mirum Pharmaceuticals, Inc (MIRM) Chart:
Mirum Pharmaceuticals, Inc (MIRM) News:
Below you will find a list of latest news for Mirum Pharmaceuticals, Inc (MIRM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Mirum Pharmaceuticals, Inc (MIRM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-20 | 20 | 0 | CALL | 0 | 0 | 240.15 | TRUE | 0 | 0 |
| 2025-06-20 | 22.5 | 0 | CALL | 0 | 0 | 195.46 | TRUE | 0 | 0 |
| 2025-06-20 | 25 | 0 | CALL | 0 | 0 | 131.01 | TRUE | 0 | 0 |
| 2025-06-20 | 30 | 0 | CALL | 0 | 0 | 123.12 | TRUE | 0 | 0 |
| 2025-06-20 | 35 | 0 | CALL | 0 | 0 | 83.53 | TRUE | 0 | 0 |
| 2025-06-20 | 40 | 0 | CALL | 0 | 4 | 55.37 | TRUE | 0 | 0 |
| 2025-06-20 | 45 | 1.65 | CALL | 0 | 17 | 64.57 | TRUE | 0 | 0 |
| 2025-06-20 | 50 | 0.9 | CALL | 9 | 100 | 62.93 | FALSE | 0.1 | 0.13 |
| 2025-06-20 | 55 | 0 | CALL | 0 | 7 | 63.58 | FALSE | 0 | 0 |
| 2025-06-20 | 60 | 0 | CALL | 0 | 125 | 121.57 | FALSE | 0 | 0 |
| 2025-06-20 | 65 | 0 | CALL | 0 | 8 | 181.78 | FALSE | 0 | 0 |
| 2025-06-20 | 70 | 0 | CALL | 0 | 0 | 215.95 | FALSE | 0 | 0 |
| 2025-06-20 | 75 | 0 | CALL | 0 | 0 | 234.85 | FALSE | 0 | 0 |
| 2025-06-20 | 20 | 0 | PUT | 0 | 0 | 413.33 | FALSE | 0 | 0 |
| 2025-06-20 | 22.5 | 0 | PUT | 0 | 0 | 365.04 | FALSE | 0 | 0 |
| 2025-06-20 | 25 | 0 | PUT | 0 | 0 | 322.35 | FALSE | 0 | 0 |
| 2025-06-20 | 30 | 0 | PUT | 0 | 0 | 248.75 | FALSE | 0 | 0 |
| 2025-06-20 | 35 | 0 | PUT | 0 | 0 | 185.37 | FALSE | 0 | 0 |
| 2025-06-20 | 40 | 0.65 | PUT | 0 | 252 | 127.25 | FALSE | 0 | 0 |
| 2025-06-20 | 45 | 2.95 | PUT | 0 | 18 | 80.09 | FALSE | 0 | 0 |
| 2025-06-20 | 50 | 0 | PUT | 0 | 0 | 44.21 | TRUE | 0 | 0 |
| 2025-06-20 | 55 | 0 | PUT | 0 | 0 | 134.32 | TRUE | 0 | 0 |
| 2025-06-20 | 60 | 0 | PUT | 0 | 0 | 162.5 | TRUE | 0 | 0 |
| 2025-06-20 | 65 | 0 | PUT | 0 | 0 | 189.83 | TRUE | 0 | 0 |
| 2025-06-20 | 70 | 0 | PUT | 0 | 0 | 211.08 | TRUE | 0 | 0 |
| 2025-06-20 | 75 | 0 | PUT | 0 | 0 | 230.04 | TRUE | 0 | 0 |
| 2025-07-18 | 20 | 0 | CALL | 0 | 0 | 142.15 | TRUE | 0 | 0 |
| 2025-07-18 | 22.5 | 0 | CALL | 0 | 0 | 127.09 | TRUE | 0 | 0 |
| 2025-07-18 | 25 | 0 | CALL | 0 | 0 | 101.6 | TRUE | 0 | 0 |
| 2025-07-18 | 30 | 0 | CALL | 0 | 0 | 82.26 | TRUE | 0 | 0 |
| 2025-07-18 | 35 | 0 | CALL | 0 | 0 | 70.55 | TRUE | 0 | 0 |
| 2025-07-18 | 40 | 0 | CALL | 0 | 6 | 53.3 | TRUE | 0 | 0 |
| 2025-07-18 | 45 | 0 | CALL | 0 | 9 | 48.07 | TRUE | 0 | 0 |
| 2025-07-18 | 50 | 0 | CALL | 0 | 4 | 63.34 | FALSE | 0 | 0 |
| 2025-07-18 | 55 | 0 | CALL | 0 | 1 | 60.41 | FALSE | 0 | 0 |
| 2025-07-18 | 60 | 0 | CALL | 0 | 0 | 104.14 | FALSE | 0 | 0 |
| 2025-07-18 | 65 | 0 | CALL | 0 | 0 | 119.09 | FALSE | 0 | 0 |
| 2025-07-18 | 70 | 0 | CALL | 0 | 0 | 132.16 | FALSE | 0 | 0 |
| 2025-07-18 | 75 | 0 | CALL | 0 | 0 | 143.8 | FALSE | 0 | 0 |
| 2025-07-18 | 20 | 0 | PUT | 0 | 0 | 136.72 | FALSE | 0 | 0 |
| 2025-07-18 | 22.5 | 0 | PUT | 0 | 0 | 225.12 | FALSE | 0 | 0 |
| 2025-07-18 | 25 | 0 | PUT | 0 | 1 | 198.88 | FALSE | 0 | 0 |
| 2025-07-18 | 30 | 0 | PUT | 0 | 1 | 153.64 | FALSE | 0 | 0 |
| 2025-07-18 | 35 | 0 | PUT | 0 | 0 | 112.43 | FALSE | 0 | 0 |
| 2025-07-18 | 40 | 0 | PUT | 0 | 2 | 79.04 | FALSE | 0 | 0 |
| 2025-07-18 | 45 | 0 | PUT | 0 | 0 | 47.08 | FALSE | 0 | 0 |
| 2025-07-18 | 50 | 0 | PUT | 0 | 0 | 41.89 | TRUE | 0 | 0 |
| 2025-07-18 | 55 | 0 | PUT | 0 | 0 | 42.83 | TRUE | 0 | 0 |
| 2025-07-18 | 60 | 0 | PUT | 0 | 0 | 102.22 | TRUE | 0 | 0 |
| 2025-07-18 | 65 | 0 | PUT | 0 | 0 | 119.33 | TRUE | 0 | 0 |
| 2025-07-18 | 70 | 0 | PUT | 0 | 0 | 134.71 | TRUE | 0 | 0 |
| 2025-07-18 | 75 | 0 | PUT | 0 | 0 | 144.65 | TRUE | 0 | 0 |
| 2025-10-17 | 20 | 0 | CALL | 0 | 0 | 91.68 | TRUE | 0 | 0 |
| 2025-10-17 | 22.5 | 0 | CALL | 0 | 0 | 80.7 | TRUE | 0 | 0 |
| 2025-10-17 | 25 | 0 | CALL | 0 | 0 | 70.83 | TRUE | 0 | 0 |
| 2025-10-17 | 30 | 0 | CALL | 0 | 0 | 62.96 | TRUE | 0 | 0 |
| 2025-10-17 | 35 | 0 | CALL | 0 | 0 | 58.04 | TRUE | 0 | 0 |
| 2025-10-17 | 40 | 0 | CALL | 0 | 0 | 51.32 | TRUE | 0 | 0 |
| 2025-10-17 | 45 | 0 | CALL | 0 | 12 | 45.32 | TRUE | 0 | 0 |
| 2025-10-17 | 50 | 0 | CALL | 0 | 0 | 48.77 | FALSE | 0 | 0 |
| 2025-10-17 | 55 | 0 | CALL | 0 | 14 | 49.73 | FALSE | 0 | 0 |
| 2025-10-17 | 60 | 1.7 | CALL | 0 | 58 | 61.57 | FALSE | 0 | 0 |
| 2025-10-17 | 65 | 0 | CALL | 0 | 2 | 58.63 | FALSE | 0 | 0 |
| 2025-10-17 | 70 | 0 | CALL | 0 | 1 | 74.94 | FALSE | 0 | 0 |
| 2025-10-17 | 75 | 0 | CALL | 0 | 2 | 81.68 | FALSE | 0 | 0 |
| 2025-10-17 | 20 | 0 | PUT | 0 | 0 | 79.51 | FALSE | 0 | 0 |
| 2025-10-17 | 22.5 | 0 | PUT | 0 | 0 | 130.91 | FALSE | 0 | 0 |
| 2025-10-17 | 25 | 0 | PUT | 0 | 0 | 115.8 | FALSE | 0 | 0 |
| 2025-10-17 | 30 | 0 | PUT | 0 | 1 | 89.78 | FALSE | 0 | 0 |
| 2025-10-17 | 35 | 0 | PUT | 0 | 0 | 67.42 | FALSE | 0 | 0 |
| 2025-10-17 | 40 | 0 | PUT | 0 | 1 | 47.82 | FALSE | 0 | 0 |
| 2025-10-17 | 45 | 0 | PUT | 0 | 8 | 45.36 | FALSE | 0 | 0 |
| 2025-10-17 | 50 | 7.6 | PUT | 0 | 6 | 44.45 | TRUE | 0 | 0 |
| 2025-10-17 | 55 | 0 | PUT | 0 | 0 | 45.17 | TRUE | 0 | 0 |
| 2025-10-17 | 60 | 0 | PUT | 0 | 0 | 46.06 | TRUE | 0 | 0 |
| 2025-10-17 | 65 | 0 | PUT | 0 | 0 | 45.2 | TRUE | 0 | 0 |
| 2025-10-17 | 70 | 0 | PUT | 0 | 0 | 81.18 | TRUE | 0 | 0 |
| 2025-10-17 | 75 | 0 | PUT | 0 | 0 | 89.67 | TRUE | 0 | 0 |
| 2025-12-19 | 15 | 0 | CALL | 0 | 0 | 102.68 | TRUE | 0 | 0 |
| 2025-12-19 | 17.5 | 0 | CALL | 0 | 0 | 83.32 | TRUE | 0 | 0 |
| 2025-12-19 | 20 | 0 | CALL | 0 | 0 | 72.68 | TRUE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | CALL | 0 | 0 | 66.8 | TRUE | 0 | 0 |
| 2025-12-19 | 25 | 0 | CALL | 0 | 2 | 69.38 | TRUE | 0 | 0 |
| 2025-12-19 | 30 | 0 | CALL | 0 | 0 | 59.83 | TRUE | 0 | 0 |
| 2025-12-19 | 35 | 0 | CALL | 0 | 4 | 57.28 | TRUE | 0 | 0 |
| 2025-12-19 | 40 | 0 | CALL | 0 | 45 | 53.33 | TRUE | 0 | 0 |
| 2025-12-19 | 45 | 0 | CALL | 0 | 0 | 48.61 | TRUE | 0 | 0 |
| 2025-12-19 | 50 | 0 | CALL | 0 | 56 | 49.89 | FALSE | 0 | 0 |
| 2025-12-19 | 55 | 0 | CALL | 0 | 1 | 49.7 | FALSE | 0 | 0 |
| 2025-12-19 | 60 | 0 | CALL | 0 | 15 | 49.12 | FALSE | 0 | 0 |
| 2025-12-19 | 65 | 0 | CALL | 0 | 186 | 55.49 | FALSE | 0 | 0 |
| 2025-12-19 | 70 | 0 | CALL | 0 | 0 | 59.9 | FALSE | 0 | 0 |
| 2025-12-19 | 75 | 0 | CALL | 0 | 1 | 66.92 | FALSE | 0 | 0 |
| 2025-12-19 | 15 | 0 | PUT | 0 | 0 | 85.01 | FALSE | 0 | 0 |
| 2025-12-19 | 17.5 | 0 | PUT | 0 | 0 | 139.55 | FALSE | 0 | 0 |
| 2025-12-19 | 20 | 0 | PUT | 0 | 1 | 71.92 | FALSE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | PUT | 0 | 3 | 109.02 | FALSE | 0 | 0 |
| 2025-12-19 | 25 | 0 | PUT | 0 | 1 | 96.52 | FALSE | 0 | 0 |
| 2025-12-19 | 30 | 0 | PUT | 0 | 2 | 75.01 | FALSE | 0 | 0 |
| 2025-12-19 | 35 | 0 | PUT | 0 | 2 | 57.09 | FALSE | 0 | 0 |
| 2025-12-19 | 40 | 0 | PUT | 0 | 989 | 48.93 | FALSE | 0 | 0 |
| 2025-12-19 | 45 | 0 | PUT | 0 | 9 | 46.3 | FALSE | 0 | 0 |
| 2025-12-19 | 50 | 8.2 | PUT | 0 | 1 | 44.61 | TRUE | 0 | 0 |
| 2025-12-19 | 55 | 0 | PUT | 0 | 0 | 44.64 | TRUE | 0 | 0 |
| 2025-12-19 | 60 | 0 | PUT | 0 | 0 | 45.99 | TRUE | 0 | 0 |
| 2025-12-19 | 65 | 0 | PUT | 0 | 0 | 47.36 | TRUE | 0 | 0 |
| 2025-12-19 | 70 | 0 | PUT | 0 | 0 | 46.88 | TRUE | 0 | 0 |
| 2025-12-19 | 75 | 0 | PUT | 0 | 0 | 75.8 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 0 | CALL | 0 | 0 | 73.9 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 0 | CALL | 0 | 0 | 60.21 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 0 | CALL | 0 | 0 | 58.52 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | CALL | 0 | 0 | 54.38 | TRUE | 0 | 0 |
| 2026-01-16 | 40 | 0 | CALL | 0 | 0 | 53.45 | TRUE | 0 | 0 |
| 2026-01-16 | 45 | 0 | CALL | 0 | 0 | 50.12 | TRUE | 0 | 0 |
| 2026-01-16 | 50 | 5.46 | CALL | 2 | 0 | 47.79 | FALSE | 5.46 | 0 |
| 2026-01-16 | 55 | 0 | CALL | 0 | 0 | 49.82 | FALSE | 0 | 0 |
| 2026-01-16 | 60 | 0 | CALL | 0 | 0 | 50.42 | FALSE | 0 | 0 |
| 2026-01-16 | 65 | 0 | CALL | 0 | 1 | 52.1 | FALSE | 0 | 0 |
| 2026-01-16 | 22.5 | 0 | PUT | 0 | 0 | 102.82 | FALSE | 0 | 0 |
| 2026-01-16 | 25 | 0 | PUT | 0 | 0 | 90.7 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 0 | PUT | 0 | 0 | 70.56 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 0 | 55.32 | FALSE | 0 | 0 |
| 2026-01-16 | 40 | 0 | PUT | 0 | 0 | 49.09 | FALSE | 0 | 0 |
| 2026-01-16 | 45 | 5 | PUT | 2 | 0 | 40.18 | FALSE | 5 | 0 |
| 2026-01-16 | 50 | 0 | PUT | 0 | 0 | 45.52 | TRUE | 0 | 0 |
| 2026-01-16 | 55 | 0 | PUT | 0 | 0 | 45.16 | TRUE | 0 | 0 |
| 2026-01-16 | 60 | 0 | PUT | 0 | 0 | 46.95 | TRUE | 0 | 0 |
| 2026-01-16 | 65 | 0 | PUT | 0 | 0 | 46.39 | TRUE | 0 | 0 |
Latest MIRM Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 4 | $20.27 |
| Jun 13, 2022 7:59 PM EST | 34 | $20.26 |
| Jun 13, 2022 7:59 PM EST | 50 | $20.26 |
| Jun 13, 2022 7:59 PM EST | 50 | $20.26 |
| Jun 13, 2022 7:59 PM EST | 100 | $20.24 |
Mirum Pharmaceuticals, Inc (MIRM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm |
| 2019-06-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1759425/000000000019010501/0000000000-19-010501-index.htm |
| 2019-07-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1759425/000000000019010921/0000000000-19-010921-index.htm |
| 2019-12-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1759425/000000000019016859/0000000000-19-016859-index.htm |
| 2020-08-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1759425/000000000020007237/0000000000-20-007237-index.htm |
| 2019-12-27 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1759425/000095012319012069/0000950123-19-012069-index.htm |
| 2019-07-30 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1759425/000107261319000249/0001072613-19-000249-index.htm |
| 2019-12-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759425/000117266119002410/0001172661-19-002410-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759425/000117266120000737/0001172661-20-000737-index.htm |
| 2019-06-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1759425/000119312519184371/0001193125-19-184371-index.htm |
| 2019-07-08 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1759425/000119312519189959/0001193125-19-189959-index.htm |
| 2019-07-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1759425/000119312519189965/0001193125-19-189965-index.htm |
| 2019-07-12 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1759425/000119312519193277/0001193125-19-193277-index.htm |
| 2019-07-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1759425/000119312519193289/0001193125-19-193289-index.htm |
| 2019-07-15 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1759425/000119312519194022/0001193125-19-194022-index.htm |
| 2019-07-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1759425/000119312519194112/0001193125-19-194112-index.htm |
| 2019-07-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1759425/000119312519194115/0001193125-19-194115-index.htm |
| 2019-07-18 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1759425/000119312519196500/0001193125-19-196500-index.htm |
| 2019-07-23 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1759425/000119312519200063/0001193125-19-200063-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000119312519202499/0001193125-19-202499-index.htm |
| 2019-07-26 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1759425/000119312519204056/0001193125-19-204056-index.htm |
| 2019-08-01 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1759425/000119312519210092/0001193125-19-210092-index.htm |
| 2019-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000119312519232419/0001193125-19-232419-index.htm |
| 2019-08-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1759425/000119312519232544/0001193125-19-232544-index.htm |
| 2019-12-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000119312519324949/0001193125-19-324949-index.htm |
| 2020-01-06 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1759425/000119312520002291/0001193125-20-002291-index.htm |
| 2020-01-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1759425/000119312520002347/0001193125-20-002347-index.htm |
| 2020-01-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1759425/000119312520002352/0001193125-20-002352-index.htm |
| 2020-01-09 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1759425/000119312520004784/0001193125-20-004784-index.htm |
| 2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000119312520007165/0001193125-20-007165-index.htm |
| 2020-01-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1759425/000119312520009903/0001193125-20-009903-index.htm |
| 2020-04-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1759425/000119312520126318/0001193125-20-126318-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000119380519000651/0001193805-19-000651-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm |
| 2019-07-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759425/000119380519000662/0001193805-19-000662-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759425/000119380520000192/0001193805-20-000192-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042429/0001209191-19-042429-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042433/0001209191-19-042433-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042435/0001209191-19-042435-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042437/0001209191-19-042437-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042439/0001209191-19-042439-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042441/0001209191-19-042441-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042442/0001209191-19-042442-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042445/0001209191-19-042445-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042446/0001209191-19-042446-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042447/0001209191-19-042447-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042448/0001209191-19-042448-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042449/0001209191-19-042449-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042451/0001209191-19-042451-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042453/0001209191-19-042453-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042454/0001209191-19-042454-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042455/0001209191-19-042455-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042456/0001209191-19-042456-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042457/0001209191-19-042457-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042458/0001209191-19-042458-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042460/0001209191-19-042460-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042470/0001209191-19-042470-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042476/0001209191-19-042476-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042479/0001209191-19-042479-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042482/0001209191-19-042482-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042486/0001209191-19-042486-index.htm |
| 2019-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042489/0001209191-19-042489-index.htm |
| 2019-07-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042657/0001209191-19-042657-index.htm |
| 2019-07-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043021/0001209191-19-043021-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm |
| 2019-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm |
| 2019-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm |
| 2019-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm |
| 2019-10-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119054233/0001209191-19-054233-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919119054240/0001209191-19-054240-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120000307/0001209191-20-000307-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120003335/0001209191-20-003335-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120003338/0001209191-20-003338-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120003342/0001209191-20-003342-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120003345/0001209191-20-003345-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120003348/0001209191-20-003348-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm |
| 2020-04-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120026416/0001209191-20-026416-index.htm |
| 2020-04-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120026418/0001209191-20-026418-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120036572/0001209191-20-036572-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120036581/0001209191-20-036581-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120036587/0001209191-20-036587-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120036594/0001209191-20-036594-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120036597/0001209191-20-036597-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120036618/0001209191-20-036618-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm |
| 2019-07-16 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1759425/000135445719000353/0001354457-19-000353-index.htm |
| 2019-09-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759425/000139506419000029/0001395064-19-000029-index.htm |
| 2019-08-28 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1759425/000156459019033345/0001564590-19-033345-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000156459019040998/0001564590-19-040998-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1759425/000156459019041030/0001564590-19-041030-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000156459020010454/0001564590-20-010454-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1759425/000156459020010471/0001564590-20-010471-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1759425/000156459020019713/0001564590-20-019713-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1759425/000156459020019725/0001564590-20-019725-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000156459020022831/0001564590-20-022831-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1759425/000156459020022856/0001564590-20-022856-index.htm |
| 2020-05-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1759425/000156459020023010/0001564590-20-023010-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000156459020029555/0001564590-20-029555-index.htm |
| 2020-08-03 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1759425/000156459020035305/0001564590-20-035305-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759425/000156459020037717/0001564590-20-037717-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1759425/000156459020037771/0001564590-20-037771-index.htm |
| 2020-08-10 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1759425/000156459020038927/0001564590-20-038927-index.htm |
| 2019-07-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1759425/999999999519001627/9999999995-19-001627-index.htm |
| 2020-01-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1759425/999999999520000041/9999999995-20-000041-index.htm |
| 2020-08-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1759425/999999999520002122/9999999995-20-002122-index.htm |
| 2019-07-10 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1759425/999999999719006082/9999999997-19-006082-index.htm |
Mirum Pharmaceuticals, Inc (MIRM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirum Pharmaceuticals, Inc (MIRM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 909%Institutional Ownership: 7089%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-09-10 | Laura Brege | Director | Buy | 10,000.00 | 11.22 | 112,200.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/0001209191-19-049309-index.htm |
| 2019-09-06 | Pamela Vig | Chief Scientific Officer | Buy | 1,600.00 | 10.96 | 17,539.20 | 1,600.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm |
| 2019-09-06 | Pamela Vig | Chief Scientific Officer | Buy | 12.00 | 11.88 | 142.56 | 1,612.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049091/0001209191-19-049091-index.htm |
| 2019-07-22 | James E Flynn | 10% Share Holder | Buy | 166,000.00 | 15.00 | 2,490,000.00 | 166,000.00 | https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm |
| 2019-09-06 | Laurent Fischer | Director | Buy | 1,720.00 | 10.71 | 18,429.28 | 1,720.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm |
| 2019-07-22 | James E Flynn | 10% Share Holder | Buy | 166,000.00 | 15.00 | 2,490,000.00 | 1,724,456.00 | https://www.sec.gov/Archives/edgar/data/1759425/000119380519000660/0001193805-19-000660-index.htm |
| 2019-09-06 | Ian Clements | SVP Finance & Communications | Buy | 1,801.00 | 11.07 | 19,937.07 | 1,801.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm |
| 2019-07-22 | Niall O'Donnell | Director | Buy | 300,000.00 | 15.00 | 4,500,000.00 | 1,921,118.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043023/0001209191-19-043023-index.htm |
| 2019-09-06 | Christopher Peetz | President and CEO | Buy | 4,750.00 | 10.91 | 51,805.88 | 192,250.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm |
| 2019-09-09 | Christopher Peetz | President and CEO | Buy | 2,000.00 | 10.90 | 21,800.00 | 194,250.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm |
| 2019-09-09 | Christopher Peetz | President and CEO | Buy | 2,320.00 | 11.35 | 26,332.00 | 196,570.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049090/0001209191-19-049090-index.htm |
| 2019-07-22 | Holdings A/S Novo | 10% Share Holder | Buy | 575,000.00 | 15.00 | 8,625,000.00 | 2,445,147.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119042970/0001209191-19-042970-index.htm |
| 2020-10-30 | Edwin Jonathan Tucker | Chief Medical Officer | Buy | 25,000.00 | 7.70 | 192,500.00 | 31,000.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919120056690/0001209191-20-056690-index.htm |
| 2019-09-09 | Laurent Fischer | Director | Buy | 1,670.00 | 10.54 | 17,601.80 | 3,390.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm |
| 2020-03-19 | Edwin Jonathan Tucker | Chief Medical Officer | Buy | 2,000.00 | 9.91 | 19,818.00 | 3,500.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm |
| 2019-07-22 | Frazier Life Sciences IX, L.P. | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 3,566,912.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043024/0001209191-19-043024-index.htm |
| 2019-07-22 | Patrick J Heron | Director | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 3,566,912.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043022/0001209191-19-043022-index.htm |
| 2019-09-09 | Laurent Fischer | Director | Buy | 300.00 | 11.30 | 3,390.00 | 3,690.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm |
| 2019-09-06 | Ian Clements | SVP Finance & Communications | Buy | 2,199.00 | 11.87 | 26,102.13 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049092/0001209191-19-049092-index.htm |
| 2019-07-22 | Ali Behbahani | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043055/0001209191-19-043055-index.htm |
| 2019-07-22 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043057/0001209191-19-043057-index.htm |
| 2019-07-22 | Carmen Chang | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043056/0001209191-19-043056-index.htm |
| 2019-07-22 | DAVID M MOTT | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043060/0001209191-19-043060-index.htm |
| 2019-07-22 | FOREST BASKETT | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043054/0001209191-19-043054-index.htm |
| 2019-07-22 | JOSHUA MAKOWER | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043059/0001209191-19-043059-index.htm |
| 2019-07-22 | Mohamad Makhzoumi | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043058/0001209191-19-043058-index.htm |
| 2019-07-22 | New Enterprise Associates 16, L.P. | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043052/0001209191-19-043052-index.htm |
| 2019-07-22 | Paul Edward Walker | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043063/0001209191-19-043063-index.htm |
| 2019-07-22 | PETER J BARRIS | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043053/0001209191-19-043053-index.htm |
| 2019-07-22 | Peter W. Sonsini | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043062/0001209191-19-043062-index.htm |
| 2019-07-22 | SCOTT D SANDELL | 10% Share Holder | Buy | 450,000.00 | 15.00 | 6,750,000.00 | 4,186,243.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119043061/0001209191-19-043061-index.htm |
| 2019-09-10 | Laurent Fischer | Director | Buy | 960.00 | 10.29 | 9,881.47 | 4,650.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119049089/0001209191-19-049089-index.htm |
| 2019-09-16 | Laurent Fischer | Director | Buy | 452.00 | 9.47 | 4,280.44 | 5,102.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm |
| 2020-03-20 | Edwin Jonathan Tucker | Chief Medical Officer | Buy | 2,500.00 | 11.90 | 29,740.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919120020665/0001209191-20-020665-index.htm |
| 2019-09-17 | Laurent Fischer | Director | Buy | 1,648.00 | 9.37 | 15,435.17 | 6,750.00 | https://www.sec.gov/Archives/edgar/data/1759425/000120919119050105/0001209191-19-050105-index.htm |